Cargando…
Metabolomics implicate eicosanoids in severe functional mitral regurgitation
AIMS: Secondary, or functional, mitral regurgitation (FMR) was recently recognized as a separate clinical entity, complicating heart failure with reduced ejection fraction (HFrEF) and entailing particularly poor outcome. Currently, there is a lack of targeted therapies for FMR due to the fact that p...
Autores principales: | Hofbauer, Thomas M., Distelmaier, Klaus, Muqaku, Besnik, Spinka, Georg, Seidl, Veronika, Arfsten, Henrike T., Hagn, Gerhard, Meier‐Menches, Samuel, Bartko, Philipp E., Pavo, Noemi, Hoke, Matthias, Prausmueller, Suriya, Heitzinger, Gregor, Pils, Dietmar, Lang, Irene M., Hengstenberg, Christian, Hülsmann, Martin P., Gerner, Christopher, Goliasch, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871691/ https://www.ncbi.nlm.nih.gov/pubmed/36217578 http://dx.doi.org/10.1002/ehf2.14160 |
Ejemplares similares
-
An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid Regurgitation
por: Spinka, Georg, et al.
Publicado: (2020) -
Malnutrition outweighs the effect of the obesity paradox
por: Prausmüller, Suriya, et al.
Publicado: (2022) -
Secondary mitral regurgitation—Insights from microRNA assessment
por: Spinka, Georg, et al.
Publicado: (2020) -
Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study
por: Bartko, Philipp E, et al.
Publicado: (2021) -
Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2019)